Infant Bacterial Therapeutics AB (publ) (IBT-B.ST)

SEK 50.8

(-4.87%)

Annual Income Statements

(In SEK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 77 Thousand 12 Thousand - - - -
Cost of Revenue - - - - 816 Thousand 816 Thousand
Gross Profit 77 Thousand 12 Thousand - - -816 Thousand -816 Thousand
Operating Expenses 134.69 Million 65.8 Million 44.57 Million 71.91 Million 47.2 Million 39.41 Million
Selling, General and Administrative Expenses 14.57 Million 1.01 Million 1.11 Million 1.13 Million 1.23 Million 1.08 Million
Research and Development Expenses 121.18 Million 65.82 Million 44.67 Million 72.23 Million 47.2 Million 39.41 Million
Other Expenses -1.06 Million -12 Thousand -94 Thousand -312 Thousand - -
Cost and Expenses 134.69 Million 65.8 Million 44.57 Million 71.91 Million 47.2 Million 39.41 Million
Operating Income -134.61 Million -65.8 Million -44.57 Million -71.91 Million -47.2 Million -39.41 Million
Interest Expense - 293 Thousand 413 Thousand 303 Thousand 725 Thousand 1.51 Million
Income Tax Expense - -357 Thousand 413 Thousand 303 Thousand 725 Thousand 327 Thousand
Earnings before Tax -123.06 Million -65.45 Million -44.99 Million -72 Million -46.32 Million -40.6 Million
Net Income -123.06 Million -65.09 Million -45.4 Million -72.31 Million -47.04 Million -40.6 Million
Earnings Per Share Basic -9.95 -5.80 -4.04 -6.44 -4.19 -3.76
Earnings Per Share Diluted -9.95 -5.80 -4.04 -6.44 -4.19 -3.76
Weighted Average Shares Outstanding 12.36 Million 11.22 Million 11.22 Million 11.22 Million 11.22 Million 10.78 Million
Weighted Average Shares Outstanding (Diluted) 12.36 Million 11.22 Million 11.22 Million 11.22 Million 11.22 Million 10.78 Million
Gross Margin 1.00 1.00 - - - -
EBIT Margin 149.99 -5361.83 - - - -
Profit Margin -1598.29 -5424.50 - - - -
EBITDA 11.54 Million -65.45 Million -44.99 Million -72 Million -45.5 Million -39.79 Million
Earnings Before Tax Margin -1748.27 -5484.00 - - - -

Income Statement Charts